Safety and Tolerance of Increased Doses of HRS-5346 Tablets in Healthy Subjects

NCT06441227 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Lipoprotein Disorder Disease

Interventions

DRUG: HRS-5346 tablets
DRUG: placebo

Sponsor

Shandong Suncadia Medicine Co., Ltd.